Categories
· Health/Science
· COPD
|
Jump to full article: The Lancet, 2009-08-29
Intro: Beyond tobacco: discussion of COPD risk factors, including pollution, TB, and chronic asthma.
COPD—more than just tobacco smoke
Phosphodiesterase-4 inhibition in COPD
From BODE to ADO to outcomes in multimorbid COPD patients
Inhaled corticosteroids in COPD and the risk of pneumonia
Time to define the disorders of the syndrome of COPD
Telemedicine for management of patients with COPD?
Leonardo Fabbri: investigating the complexity of COPD
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index
Budesonide and the risk of pneumonia: a meta-analysis of individual patient data
Screening for and early detection of chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease in non-smokers
New drugs for exacerbations of chronic obstructive pulmonary disease
Jump to full article » |